"Designing Growth Strategies is in our DNA"

Nuclear Medicine Market to Record 19.5% CAGR from 2023 to 2030; GE Healthcare Expands Portfolio with Acquisition of Zionexa and FDA Approval of Cerianna for Metastatic Breast Cancer

 

Request a Sample




We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X